Literature DB >> 9063039

The association of lifetime psychiatric illness and increased retinopathy in patients with type I diabetes mellitus.

S T Cohen1, G Welch, A M Jacobson, M De Groot, J Samson.   

Abstract

Forty-nine patients with Type I diabetes mellitus were assessed to examine the relationship between lifetime prevalence of psychiatric illness and retinopathy severity. The subjects with a history of psychiatric illness had significantly worse retinopathy than the subjects without psychiatric illness. Eighty-nine percent of the subjects with severe nonproliferative retinopathy or proliferative retinopathy had a history of psychiatric illness, predominantly affective illness. In addition, the subjects with a history of psychiatric illness had significantly higher current glycohemoglobin levels than those with no psychiatric history. This study's findings suggest that psychiatric illness may be a risk factor for development of retinopathy in Type I diabetic patients.

Entities:  

Mesh:

Year:  1997        PMID: 9063039     DOI: 10.1016/S0033-3182(97)71477-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  11 in total

1.  The Prevalence and Correlates of Mental and Emotional Health Among American Indian Adults With Type 2 Diabetes.

Authors:  Melissa L Walls; Benjamin D Aronson; Garrett V Soper; Michelle D Johnson-Jennings
Journal:  Diabetes Educ       Date:  2014-02-21       Impact factor: 2.140

2.  The evaluation of the Turkish version of the Well-being Questionnaire (WBQ-22) in patients with Type 2 diabetes: the effects of diabetic complications.

Authors:  H Savli; A Sevinc
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

Review 3.  The association between diabetes and depression: a very disabling condition.

Authors:  Vincenzo Fiore; Massimo Marci; Antonella Poggi; Vito Angelo Giagulli; Brunella Licchelli; Massimo Iacoviello; Edoardo Guastamacchia; Giovanni De Pergola; Vincenzo Triggiani
Journal:  Endocrine       Date:  2014-06-14       Impact factor: 3.633

4.  Improvement in glycemic control following a diabetes education intervention is associated with change in diabetes distress but not change in depressive symptoms.

Authors:  Sofija E Zagarins; Nancy A Allen; Jane L Garb; Garry Welch
Journal:  J Behav Med       Date:  2011-06-21

5.  Exploring the relationship between diabetes self-efficacy, depressive symptoms, and glycemic control among men and women with type 2 diabetes.

Authors:  Andrea Cherrington; Kenneth A Wallston; Russell L Rothman
Journal:  J Behav Med       Date:  2010-02

6.  Examining a bidirectional association between depressive symptoms and diabetes.

Authors:  Sherita Hill Golden; Mariana Lazo; Mercedes Carnethon; Alain G Bertoni; Pamela J Schreiner; Ana V Diez Roux; Hochang Benjamin Lee; Constantine Lyketsos
Journal:  JAMA       Date:  2008-06-18       Impact factor: 56.272

7.  Glycemic control, coping, and internalizing and externalizing symptoms in adolescents with type 1 diabetes: a cross-lagged longitudinal approach.

Authors:  Koen Luyckx; Inge Seiffge-Krenke; Sarah E Hampson
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

Review 8.  Eating disorders and type 1 diabetes mellitus in adolescence.

Authors:  V Grylli; A Karwautz; A Hafferl-Gattermayer; E Schober
Journal:  Eat Weight Disord       Date:  2003-06       Impact factor: 4.652

Review 9.  The relationship between diabetic retinopathy and psychosocial functioning: a systematic review.

Authors:  Krystal Khoo; Ryan E K Man; Gwyn Rees; Preeti Gupta; Ecosse L Lamoureux; Eva K Fenwick
Journal:  Qual Life Res       Date:  2019-03-16       Impact factor: 4.147

10.  Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study.

Authors:  Mark L Wahlqvist; Meei-Shyuan Lee; Shao-Yuan Chuang; Chih-Cheng Hsu; Hsin-Ni Tsai; Shu-Han Yu; Hsing-Yi Chang
Journal:  BMC Med       Date:  2012-11-29       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.